For individuals in the UK seeking support with weight management today, options recommended within the NHS framework include: Lifestyle interventions as first-line management, supported through Tier 2 community weight management services Orlistat for eligible patients, available via GP prescription Semaglutide (Wegovy) MHRA-licensed for chronic weight management and recommended by NICE (TA875) for use within specialist Tier 3 weight management services for qualifying patients, subject to eligibility criteria including BMI thresholds and weight-related comorbidities
This medication is taken once daily on an empty stomach, at least 30 minutes before the first food, beverage, or other oral medication of the day
The gradual drift in eating habits typically goes unnoticed until documented
This timeframe allows providers to assess: Side effect severity Appetite changes Energy levels Overall tolerance If side effects are present but mild, staying at the starting dose longer often leads to improvement without sacrificing progress
Weight change: 1-2 pounds this week (10-13 pounds total)
J., Fledelius, C., Knudsen, L
